Myeloma Paper of the Day, September 4rd, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Population-based study by Nordic Myeloma Study Group of upfront ASCT in myeloma pts aged >65 years finds improving 3- and 5-year OS trend with more recent transplant dates, low 100-day mortality mostly before daratumumab era.”
Title: Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group
Authors: Kari Lenita Falck Moore, Samundur Rognvaldsson, Agoston G Szabo, Vilmantė Vaitekėnaitė, Diana Loigom, Anna Genell, Jonathan Thorsen, Jakob N Norgaard, Sigrun Thorsteinsdottir, Dorota Knut-Bojanowska, Anna Lysen, Fredrik Schjesvold, Valdas Peceliunas, Ain Kaare, Katrin Palk, Maris Parnat, Alexander Sigurdsson, Annette J Vangsted, Cecilie H Blimark
More posts featuring Robert Orlowski on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023